Prothena Corp Public (PRTA) Gains from Investment Securities (2013 - 2025)
Prothena Corp Public (PRTA) recorded quarterly Gains from Investment Securities of $227000.0 in Q4 2025, up 22800.0% quarter-over-quarter from -$1000.0 in Q3 2025.
Prothena Corp Public (PRTA) Gains from Investment Securities (2013 - 2025) Analysis & Trends
Prothena Corp Public's Gains from Investment Securities history runs 8 years deep, the most recent figure standing at $227000.0 for Q4 2025.
- In Q4 2025, Gains from Investment Securities changed N/A year-over-year to $227000.0; the TTM figure through Mar 2026 stood at $226000.0 (up 11400.0% YoY), while the FY2025 annual figure was $224000.0, changed N/A from the prior year.
- Gains from Investment Securities was $227000.0 for Q4 2025 at Prothena Corp Public, up from -$1000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $3.5 million in Q3 2023 to a low of -$3.8 million in Q4 2023.
- Historically, Gains from Investment Securities has averaged $260727.3 across 4 years, with a median of $142000.0 in 2022.
- The sharpest annual moves came in 2022 and 2023: Gains from Investment Securities surged 135.32% in 2022, then slumped 252.51% in 2023.
- A 4-year view of Gains from Investment Securities shows it stood at -$402000.0 in 2021, then soared by 723.88% to $2.5 million in 2022, then plunged by 252.51% to -$3.8 million in 2023, then soared by 105.93% to $227000.0 in 2025.
- The last three Gains from Investment Securities figures came in at $227000.0 (Q4 2025), -$1000.0 (Q3 2025), and -$2000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Prothena Corp Public | 479.08 Mn | 149.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 227,000.00 |
| Dec 31, 2025 | 227,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Mar 31, 2025 | -2,000.00 |
| Mar 31, 2025 | -2,000.00 |
| Dec 31, 2023 | -3.83 Mn |
| Dec 31, 2023 | -3.83 Mn |
| Sep 30, 2023 | 3.48 Mn |
| Sep 30, 2023 | 3.48 Mn |
| Jun 30, 2023 | 334,000.00 |
| Jun 30, 2023 | 334,000.00 |
| Dec 31, 2022 | 2.51 Mn |
| Dec 31, 2022 | 2.51 Mn |
| Jun 30, 2022 | 142,000.00 |
| Jun 30, 2022 | 142,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Jun 30, 2021 | -402,000.00 |
| Jun 30, 2021 | -402,000.00 |